newsfilter
← Latest News
GlobeNewswire·

ObsEva Announces Symposium and Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at SEUD Congress 2021

GENEVA, Switzerland December 2, 2021 – ObsEva SA (NASDAQ:OBSV, SIX: OBSN))), a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health, today announced a symposium and three oral presentations on